ClinicalTrials.Veeva

Menu

Opioid-Free Pain Control Regiment Following Robotic Radical Prostatectomy

Wake Forest University (WFU) logo

Wake Forest University (WFU)

Status and phase

Withdrawn
Phase 3
Phase 2

Conditions

Radical Prostatectomies

Treatments

Drug: Gabapentin
Drug: Acetaminophen
Drug: Oxycodone-Acetaminophen
Drug: Ketorolac
Drug: Tramadol
Drug: Ketorolac tromethamine
Drug: Ketamine
Drug: Hydrocodone-Acetaminophen

Study type

Interventional

Funder types

Other

Identifiers

NCT04939987
IRB00074034

Details and patient eligibility

About

This study will address the gaps in research of non-opioid postoperative pain management for prostatectomies.

Full description

This study will conduct a randomized control double-blind clinical trial to evaluate an opioid versus a non-opioid pathway of gabapentin, ketorolac, and acetaminophen in treating postoperative pain following robot-assisted radical prostatectomy (RARP).

Sex

Male

Ages

40 to 75 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • All men ages 40-75 undergoing bilateral robot assisted radical prostatectomy (RARP) with bilateral lymph node dissection with low-intermediate to high-risk localized prostate cancer

Exclusion criteria

  • Allergies to any medication involved in the study
  • T4 prostate cancer
  • incarcerated persons
  • chronic narcotic dependence
  • any current prescription for narcotics
  • any surgery in the past 6 months

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

0 participants in 2 patient groups

Opioid Control Cohort
Active Comparator group
Description:
One treatment selected: Tramadol (50mg) Hydrocodone-Acetaminophen (2.5mg/325mg) Oxycodone-Acetaminophen (2.5mg/325mg)
Treatment:
Drug: Hydrocodone-Acetaminophen
Drug: Tramadol
Drug: Oxycodone-Acetaminophen
Experimental Cohort
Experimental group
Description:
Multimodal Approach: Gabapentin (100mg TID) Ketorolac (15mg q6) Acetaminophen (1mg IV q6) Ketamine (1.5mg/kg) Ketorolac tromethamine (15mg or 30mg Q4)
Treatment:
Drug: Ketorolac tromethamine
Drug: Gabapentin
Drug: Acetaminophen
Drug: Ketamine
Drug: Ketorolac

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems